Logo image of RE21.DE

REDEIA CORP SA (RE21.DE) Stock Fundamental Analysis

FRA:RE21 - Deutsche Boerse Ag - ES0173093024 - Common Stock - Currency: EUR

17.8  +0.14 (+0.79%)

Fundamental Rating

4

Overall RE21 gets a fundamental rating of 4 out of 10. We evaluated RE21 against 17 industry peers in the Electric Utilities industry. RE21 has a medium profitability rating, but doesn't score so well on its financial health evaluation. RE21 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year RE21 was profitable.
In the past year RE21 had a positive cash flow from operations.
RE21 had positive earnings in each of the past 5 years.
In the past 5 years RE21 always reported a positive cash flow from operatings.
RE21.DE Yearly Net Income VS EBIT VS OCF VS FCFRE21.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

RE21 has a Return On Assets of 2.44%. This is in the lower half of the industry: RE21 underperforms 64.71% of its industry peers.
RE21 has a worse Return On Equity (7.15%) than 82.35% of its industry peers.
RE21's Return On Invested Capital of 4.57% is in line compared to the rest of the industry. RE21 outperforms 47.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RE21 is below the industry average of 8.33%.
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROIC 4.57%
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
RE21.DE Yearly ROA, ROE, ROICRE21.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 23.11%, RE21 belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
RE21's Profit Margin has declined in the last couple of years.
The Operating Margin of RE21 (44.44%) is better than 94.12% of its industry peers.
RE21's Operating Margin has declined in the last couple of years.
RE21 has a Gross Margin of 102.40%. This is amongst the best in the industry. RE21 outperforms 100.00% of its industry peers.
RE21's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
RE21.DE Yearly Profit, Operating, Gross MarginsRE21.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RE21 is destroying value.
RE21 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for RE21 has been increased compared to 5 years ago.
The debt/assets ratio for RE21 is higher compared to a year ago.
RE21.DE Yearly Shares OutstandingRE21.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RE21.DE Yearly Total Debt VS Total AssetsRE21.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that RE21 is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.30, RE21 perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
RE21 has a Debt/Equity ratio of 1.00. This is a neutral value indicating RE21 is somewhat dependend on debt financing.
RE21 has a better Debt to Equity ratio (1.00) than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.3
ROIC/WACC0.84
WACC5.42%
RE21.DE Yearly LT Debt VS Equity VS FCFRE21.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

RE21 has a Current Ratio of 1.18. This is a normal value and indicates that RE21 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, RE21 belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
RE21 has a Quick Ratio of 1.14. This is a normal value and indicates that RE21 is financially healthy and should not expect problems in meeting its short term obligations.
RE21 has a Quick ratio of 1.14. This is in the better half of the industry: RE21 outperforms 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.14
RE21.DE Yearly Current Assets VS Current LiabilitesRE21.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The earnings per share for RE21 have decreased strongly by -42.00% in the last year.
RE21 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.24% yearly.
RE21 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.96%.
Measured over the past years, RE21 shows a decrease in Revenue. The Revenue has been decreasing by -4.50% on average per year.
EPS 1Y (TTM)-42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%23.81%
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-11.24%

3.2 Future

Based on estimates for the next years, RE21 will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.26% on average per year.
RE21 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.54% yearly.
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.26%
Revenue Next Year-5.5%
Revenue Next 2Y1.78%
Revenue Next 3Y3.01%
Revenue Next 5Y3.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RE21.DE Yearly Revenue VS EstimatesRE21.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B
RE21.DE Yearly EPS VS EstimatesRE21.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.57, the valuation of RE21 can be described as expensive.
76.47% of the companies in the same industry are cheaper than RE21, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RE21 to the average of the S&P500 Index (27.50), we can say RE21 is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 15.60, the valuation of RE21 can be described as correct.
RE21's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, RE21 is valued rather cheaply.
Industry RankSector Rank
PE 26.57
Fwd PE 15.6
RE21.DE Price Earnings VS Forward Price EarningsRE21.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RE21 is valued a bit more expensive than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.83
RE21.DE Per share dataRE21.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

RE21's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RE21's earnings are expected to grow with 24.74% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y35.97%
EPS Next 3Y24.74%

4

5. Dividend

5.1 Amount

RE21 has a Yearly Dividend Yield of 3.72%. Purely for dividend investing, there may be better candidates out there.
RE21's Dividend Yield is comparable with the industry average which is at 4.53.
RE21's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 3.72%

5.2 History

The dividend of RE21 has a limited annual growth rate of 1.50%.
Dividend Growth(5Y)1.5%
Div Incr Years1
Div Non Decr Years3
RE21.DE Yearly Dividends per shareRE21.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

RE21 pays out 155.39% of its income as dividend. This is not a sustainable payout ratio.
The dividend of RE21 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP155.39%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
RE21.DE Yearly Income VS Free CF VS DividendRE21.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
RE21.DE Dividend Payout.RE21.DE Dividend Payout, showing the Payout Ratio.RE21.DE Dividend Payout.PayoutRetained Earnings

REDEIA CORP SA

FRA:RE21 (7/18/2025, 7:00:00 PM)

17.8

+0.14 (+0.79%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30
Inst Owners31.96%
Inst Owner ChangeN/A
Ins Owners5%
Ins Owner ChangeN/A
Market Cap9.63B
Analysts72
Price Target19.71 (10.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.72%
Yearly Dividend1.06
Dividend Growth(5Y)1.5%
DP155.39%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-76.82%
Min EPS beat(2)-147.36%
Max EPS beat(2)-6.28%
EPS beat(4)0
Avg EPS beat(4)-48.85%
Min EPS beat(4)-147.36%
Max EPS beat(4)-6.28%
EPS beat(8)2
Avg EPS beat(8)-22.4%
EPS beat(12)5
Avg EPS beat(12)-15.43%
EPS beat(16)8
Avg EPS beat(16)-11.7%
Revenue beat(2)0
Avg Revenue beat(2)-24.23%
Min Revenue beat(2)-45.83%
Max Revenue beat(2)-2.63%
Revenue beat(4)0
Avg Revenue beat(4)-14.78%
Min Revenue beat(4)-45.83%
Max Revenue beat(4)-2.63%
Revenue beat(8)1
Avg Revenue beat(8)-5.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.17%
PT rev (3m)2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-8.5%
Revenue NQ rev (3m)-8.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.45%
Valuation
Industry RankSector Rank
PE 26.57
Fwd PE 15.6
P/S 6.04
P/FCF N/A
P/OCF 10.08
P/B 1.87
P/tB 2.07
EV/EBITDA 12.83
EPS(TTM)0.67
EY3.76%
EPS(NY)1.14
Fwd EY6.41%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)1.77
OCFY9.92%
SpS2.95
BVpS9.53
TBVpS8.62
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROCE 5.86%
ROIC 4.57%
ROICexc 4.95%
ROICexgc 5.18%
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
FCFM N/A
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
ROICexc(3y)5.94%
ROICexc(5y)6.62%
ROICexgc(3y)6.37%
ROICexgc(5y)7.12%
ROCE(3y)6.92%
ROCE(5y)7.7%
ROICexcg growth 3Y-15.65%
ROICexcg growth 5Y-10.59%
ROICexc growth 3Y-14.67%
ROICexc growth 5Y-10.02%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.39
Cap/Depr 233.63%
Cap/Sales 67.66%
Interest Coverage 5.71
Cash Conversion 81.66%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.14
Altman-Z 1.3
F-Score6
WACC5.42%
ROIC/WACC0.84
Cap/Depr(3y)169.97%
Cap/Depr(5y)143.18%
Cap/Sales(3y)48.95%
Cap/Sales(5y)40.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%23.81%
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.26%
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-11.24%
Revenue Next Year-5.5%
Revenue Next 2Y1.78%
Revenue Next 3Y3.01%
Revenue Next 5Y3.54%
EBIT growth 1Y-23.31%
EBIT growth 3Y-9.69%
EBIT growth 5Y-8.02%
EBIT Next Year64.03%
EBIT Next 3Y25.42%
EBIT Next 5Y16.78%
FCF growth 1Y73.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.27%
OCF growth 3Y-15.88%
OCF growth 5Y-1.78%